TERN
Terns Pharmaceuticals, Inc.Company with tickers: TERN
CIK
1831363
CUSIP
880881107
Shares Outstanding
115,521,157
13F Activity (30d)
295 filings
291 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $-101,871,000 | USD | 2024-12-31 | 10-K | 2026-03-30 |
| Net Income | $-88,853,000 | USD | 2024-12-31 | 10-K | 2026-03-30 |
| EPS (Basic) | $-1.12 | USD/shares | 2024-12-31 | 10-K | 2026-03-30 |
| EPS (Diluted) | $-1.12 | USD/shares | 2024-12-31 | 10-K | 2026-03-30 |